Health Business news
Global Contrast Injector Market - Expected to Grow at a CAGR of 7.5% During 2017-2023

Global Contrast Injector Market - Expected to Grow at a CAGR of 7.5% During 2017-2023

DUBLIN, Dec. 28, 2017 /PRNewswire/ --

The "Global Contrast Injector Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to Research and Markets' offering. The global contrast injector market is expected to grow with the CAGR of approximately 7.5% during the forecast period (2016-2023).

The factors that are supporting to drive the growth of the contrast injector market are increasing prevalence of chronic diseases across the globe; increasing number of approvals for contrast agents, increasing demand for imaging procedures such as MRI, CT etc. and increasing adoption of contrast media injectors by physicians. Contrast media injectors offer features such as pre-loaded protocols and safety to avoid extravasations and support physicians during contrast media insertion. It also enables physicians for early diagnosis of chronic diseases such as cardiac and neurological disorders. Therefore, physicians are shifting towards contrast injector for better imaging and technological innovations are also further increasing the effectiveness of contrast injectors. For example: In March 2015, Bracco introduced the Empower CTA+, a touch-screen based contrast injector system for CT angiography. This allows end-users to totally modify the injection experience for every patient by simultaneous variable flow rates, saline jump and saline advance; saline advance enables the technologist to examine the patient's patency and vein integrity while saline jump supports to minimize contrast dose through enabling immediate innovation to saline, once pacification has been touched. Thus, such kind of technological innovations in contrast agents supports physicians in better diagnosis.

The global contrast injector market is segmented on the basis of product and end-user. The product segment is further classified into CT Injectors, MRI Injectors, Cardiology Injectors and Angiography Injectors. The end-user segment is further classified into ambulatory surgical centers, hospitals and diagnostics centers.

Companies Mentioned Analog Devices, Inc. (U.S.)
Canon Inc. (U.S.)
Denso Corporation (Japan)
Hewlett-Packard Company (U.S.)
Honeywell International Inc. (U.S.)
Invensense Inc. (U.S.)
Knowles Electronics, Llc. (U.S.)
Megachips Corporation (Japan)
Nxp Semiconductors (Netherland)
Panasonic Corporation (Japan)
Robert Bosch Gmbh (Germany)
Seiko Epson Corporation (Japan)
Sensata Technologies Inc. (U.S.)
ST Microelectronics (Switzerland)
Texas Instruments Inc. (U.S.)
Key Topics Covered: 1. Introduction 2. Market Overview

3. Market Determinants 4. Market Segmentation 5. Competitive Landscape 6. Geographical Analysis 7. Company Profiles For more information about this report visit
Media Contact:

Laura Wood, Senior Manager  For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:
SOURCE Research and Markets

Prev Article
Next Article

> Article Date par Research and Markets

Read: 15 views

Notes :

Source : PR Newswire


Related content

: Latest news

Most read: scientific news



Follow us...

google plus Facebook twitter Newsletter



Plan du site